Public Company News

WuXi Biologics Statement

SHANGHAI, Feb. 8, 2022 /PRNewswire/ -- We have been made aware of a recent U.S. Commerce Department announcement that two WuXi Biologics (Cayman) subsidiaries inShanghai and Wuxi will be added to the department's "Unverified List" (UVL) on February 8, 2022. We understand that the reason for this a...

2022-02-08 11:08 4004

LG Energy Solution Announces Fourth Quarter and FY 2021 Results

* Reports quarterly revenue of KRW 4.44 trillion, 10.2 percent higher than previous quarter; operating profit atKRW 76 billion * Targets revenue goal of KRW19.2 trillion with plans to spend KRW 6.3 trillion in capital expenditures for 2022 SEOUL, South Korea, Feb. 7, 2022 /PRNewswire/ -- LG E...

2022-02-08 09:10 2827

Marina Bay Sands unveils US$1 billion reinvestment to transform luxury travel and hospitality experience

SINGAPORE, Feb. 8, 2022 /PRNewswire/ -- Marina Bay Sands has embarked on a major reinvestment programme for its existing property, spanning hotel rooms and suites, new food and beverage (F&B) offerings and other enhancements that will position the Integrated Resort (IR) for strong growth as the r...

2022-02-08 08:30 4738

Bridge Biotherapeutics and Scripps Research Launch Research Collaboration to Develop Discovery Platform and Novel Covalent Probes Based on Chemical Biology and Chemoproteomics

* Two-year research collaboration to develop new reactive group chemistries targeting non-cysteine amino acids to expand druggable binding sites and identify novel targets in oncology and immunology * Collaborators at Scripps are pioneers in the field of chemical biology and chemistry SEONGNA...

2022-02-08 06:00 2374

eMemory Partners with Intel Foundry Services to Boost Security in Leading-Edge Chips

HSINCHU, Taiwan, Feb. 7, 2022 /PRNewswire/ -- eMemory Technology Inc., Asia's largest provider of semiconductor intellectual property (IP), today announced it is joining Intel Foundry Services (IFS) Accelerator – IP Alliance. The collaboration will provide the leading-edge security solutions for ...

2022-02-08 00:00 3015

Buybacks of series B shares in AB Electrolux during week 05, 2022 - buyback program completed

STOCKHOLM, Feb. 07, 2022 /PRNewswire/ -- During the period January 31 - February 03, 2022 AB Electrolux (LEI code 549300Y3HHZB1ZGFPJ93) has repurchased in total 1,327,560 own series B shares (ISIN: SE0016589188) as part of the buyback program initiated by the Board of Directors in order to optimi...

2022-02-07 23:27 2534

US FDA Study May Proceed letter for Clarity's Cu-64 SAR-bisPSMA trial in prostate cancer

SYDNEY, Feb. 7, 2022 /PRNewswire/ -- Clarity Pharmaceuticals (ASX: CU6) ("Clarity"), a clinical-stage radiopharmaceutical company developing next-generation products to address the growing needs in oncology, is pleased to announce that it has received a confirmation from the US Food and Drug Adm...

2022-02-07 22:08 2621

Pop Culture Group Announces Joint Venture to Create a First-ever Street Dance Chain SaaS Platform in China

New joint venture will accelerate the development of dance organizations in China XIAMEN, China, Feb. 7, 2022 /PRNewswire/ – Pop Culture Group Co., Ltd ("Pop Culture" or the "Company") (Nasdaq: CPOP), a hip-pop culture company inChina, announced today that a strategic partnership with an investo...

2022-02-07 22:00 2710

SmartKem, Inc. Begins Trading on the OTCQB in the US

Seeking to reshape the world of electronics with a revolutionary new organic semiconductor platform that enables a new generation of displays, sensors and logic MANCHESTER, England, Feb. 7, 2022 /PRNewswire/ -- SmartKem, Inc. (the Company) announced that its common stock has commenced trading on...

2022-02-07 21:27 3575

KAZIA THERAPEUTICS TO PRESENT AT BIO CEO CONFERENCE

SYDNEY, Feb. 7, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce that CEO, DrJames Garner, will be presenting at the BIO CEO Conference, to be held in person and virtually inNew York, NY, from 14-17 Febr...

2022-02-07 21:00 3817

Origin Agritech Issues 2022 Guidance of 300% Revenue Growth

BEIJING, Feb. 7, 2022 /PRNewswire/ -- Origin Agritech Ltd. (NASDAQ: SEED) (the "Company" or "Origin"), an agriculture technology company, announced today that it expects revenues to grow in excess of 300%, to over150 million RMB, and expects to turn a profit for fiscal 2022. The expected revenue ...

2022-02-07 20:00 3732

Samsung Biologics receives 2022 CMO Leadership Award in all six categories

INCHEON, South Korea, Feb. 7, 2022 /PRNewswire/ -- Samsung Biologics (KRX: 207940.KS), the world's leading contract development and manufacturing organization (CDMO), announced that it has been selected as a winner of the 2022 CMO Leadership Awards presented by Outsourced Pharma and Life Science ...

2022-02-07 20:00 2752

Ascletis Announces Positive Data of Oral Double Prodrug ASC10 and Its Antiviral Nucleoside Analog ASC10-A Against Omicron Variant

* ASC10-A demonstrated strong in vitro antiviral activity against multiple SARS-CoV-2 virus variants including Omicron * By applying a double prodrug strategy, ASC10's permeability in Caco-2 cells and ASC10's oral bioavailability in monkeys were 3.2-fold and 2.3-fold of Molnupiravir, respecti...

2022-02-07 19:00 4214

Invitation to teleconference/audio transmission

GÖTEBORG, Sweden, Feb. 7, 2022 /PRNewswire/ -- Concordia Maritime welcomes you to participate in a teleconference/audio transmission onFebruary 10, 2022 at 3.00 pm CET. The session will feature a presentation of the Financial Statement for the full year 2021 and a Q&A session. Presiding: Erik ...

2022-02-07 18:46 2366

Clarivate Identifies Seven Medtech Trends to Watch in 2022

LONDON, Feb. 7, 2022 /PRNewswire/ -- Clarivate Plc (NYSE: CLVT), a global leader in providing trusted information and insights to accelerate the pace of innovation, today released a new report,Outlook on the Medtech Industry: Seven Areas to Watch. The report analyzes seven factors that Clarivate ...

2022-02-07 16:00 2524

Sohu.com to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 22, 2022

BEIJING, Feb. 7, 2022 /PRNewswire/ -- Sohu.com Limited (NASDAQ: SOHU), China's leading online media, video and game business group, will report its fourth quarter and fiscal year 2021 unaudited financial results onTuesday, February 22 , 2022, before U.S. market hours. Sohu's management team wil...

2022-02-07 13:00 3999

Haitong International included in FTSE4Good Index Series

HONG KONG, Feb. 6, 2022 /PRNewswire/ -- Haitong International Securities Group Limited ("Haitong International" or "The Group"; Stock Code: 665.HK) announced today that the Group has been included in the FTSE4Good Index by global index provider FTSE Russell, which is owned by the London Stock Exc...

2022-02-07 12:36 3228

New "Captain Tsubasa: Dream Team" Dream Championship Rating System

TOKYO, Feb. 7, 2022 /PRNewswire/ -- KLab Inc., a leader in online mobile games, announced that its head-to-head football simulation gameCaptain Tsubasa: Dream Team introduced a new Rating System for the Dream Championship worldwide tournament starting fromFriday, February 4. See the original pres...

2022-02-07 11:15 3716

Antengene Announces HREC Approval in Australia for the Phase I Trial of the Small Molecule CD73 Inhibitor ATG-037

SHANGHAI and HONG KONG, Feb. 7, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hematology and o...

2022-02-07 08:30 3806

Everest Medicines Announces First Drug Approval of Trodelvy® in Singapore for Second-Line Metastatic Triple-Negative Breast Cancer

SHANGHAI, Feb. 7, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products to address critical unmet needs inAsia...

2022-02-07 08:00 5097